SOX10 (Transcription factor SOX-10) variants and mutations
SOX10 (also known as Transcription factor SOX-10) is a human protein-coding gene encoding a transcription factor SOX-10 protein. Its annotated function is transcription factor that plays a central role in developing and mature glia (By similarity). Specifically activates expression of myelin genes, during oligodendrocyte (OL) maturation, such as DUSP15 and MYRF, thereby playing a central…. It is annotated at the cytoplasm. This analysis covers 1,012 SOX10 variants and mutations. Of these, 72% have computational variant effect predictions. Disease context includes PCWH syndrome, Waardenburg syndrome type 2E, and Neurologic Waardenburg-Shah syndrome. Example SOX10 variants include M1?, A2V, and E3*.
Variant analysis overview
- Gene: SOX10
- Protein: Transcription factor SOX-10
- UniProt accession: P56693
- Organism: Homo sapiens
- Variants analyzed: 1012
- Variant scope: all variants
- Completed: 2026-08-28
Variant and mutation evidence
- Variant composition: 682 unspecified-consequence records; 2 stop lost; 138 synonymous variants; 179 missense variants; 2 stop-gained variants; 1 stop retained variant; 3 in-frame deletions; 2 in-frame insertions; 4 frameshift variants; 2 splice-region variants; 4 substitution
- Prediction scores: 733 variants have prediction scores (72% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: PCWH syndrome, Waardenburg syndrome type 2E, Neurologic Waardenburg-Shah syndrome, Waardenburg syndrome type 4C, Waardenburg syndrome, Waardenburg-Shah syndrome, deaf blind hypopigmentation syndrome, Yemenite type, neurodegenerative disease, Waardenburg syndrome type 1, hereditary disease, Kallmann syndrome, Rare genetic deafness.
Protein structure and variant hotspots
- Protein features: 1 post-translational modification sites.
- PTM context: 3 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable SOX10 variants
Examples include M1?, A2V, E3*, E4K, E4V, Q5*, Q5E, Q5H. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, cosmic curated COSV61004
- A2V (p.Ala2Val), gnomAD rs1186044024, REVEL 0.34, CADD 23.20
- E3* (p.Glu3Ter), rs1932482365, ClinGen CA411502553, ClinVar RCV001290164, Ensembl rs1932482365, CADD 36.00, Pathogenic
- E4K (p.Glu4Lys), TOPMed rs1932482258, REVEL 0.43, CADD 23.70
- E4V (p.Glu4Val), TOPMed rs1932482163
- Q5* (p.Gln5Ter), rs2145777835, ClinGen CA2499226186, ClinVar RCV001582453, Ensembl rs2145777835, CADD 37.00, Pathogenic
- Q5E (p.Gln5Glu), rs2518053075, ClinGen CA411502512, ClinVar RCV004531941, REVEL 0.47, CADD 23.00, Uncertain significance, SOX10-related disorder
- Q5H (p.Gln5His), TOPMed rs1256220050, gnomAD rs1256220050, REVEL 0.49, CADD 14.10
- Q5R (p.Gln5Arg), Ensembl rs1932481978, REVEL 0.56, CADD 22.10
- D6A (p.Asp6Ala), Ensembl rs1601887226
- D6E (p.Asp6Glu), 1000Genomes rs149435516, ESP rs149435516, ExAC rs149435516, gnomAD rs149435516, REVEL 0.33, CADD 21.00, Benign
- L7P (p.Leu7Pro), TOPMed rs1175938851, REVEL 0.42, CADD 23.80
- V10G (p.Val10Gly), Ensembl rs1601887213
- V10M (p.Val10Met), rs2518053043, ClinGen CA411502423, ClinVar RCV003696825, REVEL 0.43, CADD 23.20, Uncertain significance, not provided
- E11D (p.Glu11Asp), Ensembl rs1932480957, REVEL 0.37, CADD 17.30
- E11K (p.Glu11Lys), TOPMed rs1378332307, REVEL 0.58, CADD 23.90
- L12R (p.Leu12Arg), cosmic curated COSV61004
- S13N (p.Ser13Asn), gnomAD rs867999617
- S13R (p.Ser13Arg), gnomAD rs1228706802, REVEL 0.30, CADD 22.70
- P14A (p.Pro14Ala), rs2518053010, ClinGen CA411502347, ClinVar RCV003228541, Uncertain significance, not provided
- V15A (p.Val15Ala), rs1555939564, ClinGen CA658799549, ClinVar RCV000626403, ClinVar RCV001729642, REVEL 0.18, CADD 17.70, Pathogenic
- V15M (p.Val15Met), TOPMed rs1282410687, gnomAD rs1282410687, REVEL 0.19, CADD 21.60, Uncertain significance, not provided
- G16S (p.Gly16Ser), rs1450100008, ClinGen CA411502331, ClinVar RCV002751035, ClinVar RCV003348910, REVEL 0.23, CADD 19.90, Uncertain significance, not provided; Inborn genetic diseases
- S17* (p.Ser17Ter), rs1064795391, ClinGen CA16621120, ClinVar RCV000479482, Ensembl rs1064795391, CADD 37.00, Likely pathogenic
- S17L (p.Ser17Leu), NCI-TCGA TCGA novel, Ensembl rs1064795391, REVEL 0.47, CADD 27.20, Likely pathogenic
- E18Q (p.Glu18Gln), NCI-TCGA TCGA novel, REVEL 0.33, CADD 23.30, Variant assessed as somatic; moderate impact.
- E19G (p.Glu19Gly), TOPMed rs1334869588, gnomAD rs1334869588, REVEL 0.27, CADD 23.10
- E19K (p.Glu19Lys), cosmic curated COSV10520
- P20A (p.Pro20Ala), Ensembl rs1932479472
- R21C (p.Arg21Cys), TOPMed rs1161833735, gnomAD rs1161833735, REVEL 0.22, CADD 24.00, Uncertain significance
- R21G (p.Arg21Gly), TOPMed rs1161833735, gnomAD rs1161833735, REVEL 0.16, CADD 23.50, Uncertain significance, Inborn genetic diseases; not provided
- R21H (p.Arg21His), TOPMed rs1458159398, gnomAD rs1458159398, REVEL 0.16, CADD 21.50
- R21S (p.Arg21Ser), TOPMed rs1161833735, gnomAD rs1161833735, REVEL 0.16, CADD 22.30, Uncertain significance
- C22Y (p.Cys22Tyr), Ensembl rs1932478699, REVEL 0.20, CADD 23.30
- S24A (p.Ser24Ala), TOPMed rs1368575089, gnomAD rs1368575089, REVEL 0.24, CADD 23.00
- S24T (p.Ser24Thr), TOPMed rs1368575089, gnomAD rs1368575089
- S24Y (p.Ser24Tyr), rs1339336077, ClinGen CA411502204, ClinVar RCV000825458, ClinVar RCV002290474, REVEL 0.52, CADD 25.90, Uncertain significance, not specified; not provided
- P25S (p.Pro25Ser), cosmic curated COSV61005, Ensembl rs1932478106
- G26E (p.Gly26Glu), NCI-TCGA TCGA novel, gnomAD rs1932478012, REVEL 0.19, CADD 23.10, Variant assessed as somatic; moderate impact.
- A28V (p.Ala28Val), rs1932477803, ClinGen CA411502166, ClinVar RCV001970537, NCI-TCGA TCGA novel, REVEL 0.18, CADD 22.60, Uncertain significance, not provided
- P29H (p.Pro29His), cosmic curated COSV10590
- P29T (p.Pro29Thr), rs1489956199, ClinGen CA411502165, ClinVar RCV001767130, TOPMed rs1489956199, REVEL 0.21, CADD 21.50, Uncertain significance, not provided
- S30* (p.Ser30Ter), rs1932477493, ClinGen CA411502148, ClinVar RCV001092010, ClinVar RCV001170068, CADD 36.00, Pathogenic
- G32R (p.Gly32Arg), cosmic curated COSV10520, NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P33L (p.Pro33Leu), gnomAD rs1229987208
- P33S (p.Pro33Ser), cosmic curated COSV61005, gnomAD rs1478879510, REVEL 0.10, CADD 16.00
- P33T (p.Pro33Thr), gnomAD rs1478879510, REVEL 0.16, CADD 16.10
- D34G (p.Asp34Gly), rs2145777610, ClinGen CA411502115, ClinVar RCV002214256, Ensembl rs2145777610, REVEL 0.13, CADD 17.50, Uncertain significance, not provided
- G35D (p.Gly35Asp), NCI-TCGA Cosmic COSV1003, cosmic curated COSV10032, gnomAD rs1932476499, Variant assessed as somatic; moderate impact.
- G35S (p.Gly35Ser), cosmic curated COSV61005, REVEL 0.20, CADD 15.30
- G36D (p.Gly36Asp), cosmic curated COSV61005, REVEL 0.32, CADD 22.70
- G36N (p.Gly36Asn), cosmic curated COSV61005
- G36S (p.Gly36Ser), rs770004606, ClinGen CA10228729, ClinVar RCV003061605, ExAC rs770004606, REVEL 0.32, CADD 20.70, Uncertain significance, not provided
- G37S (p.Gly37Ser), ExAC rs759762110, gnomAD rs759762110, REVEL 0.28, CADD 23.30
- G38A (p.Gly38Ala), rs397515387, ClinGen CA129071, ClinVar RCV000023179, Pathogenic
- G38D (p.Gly38Asp), gnomAD rs1322873238, REVEL 0.19, CADD 19.10
- G38S (p.Gly38Ser), rs2518052834, ClinGen CA411502077, ClinVar RCV003361766, REVEL 0.19, CADD 18.20, Uncertain significance, not provided; Inborn genetic diseases
- G39V (p.Gly39Val), gnomAD rs1436063707, REVEL 0.14, CADD 21.20
- S40L (p.Ser40Leu), cosmic curated COSV10942, REVEL 0.22, CADD 22.50
- G41D (p.Gly41Asp), rs199750760, ClinGen CA411502036, ClinVar RCV002899556, 1000Genomes rs199750760, REVEL 0.15, CADD 21.60, Uncertain significance, not provided
- G41V (p.Gly41Val), rs199750760, ClinGen CA10228725, ClinVar RCV000277103, ClinVar RCV000325156, REVEL 0.17, CADD 22.90, Benign/Likely benign, Waardenburg syndrome; not provided; PCWH syndrome
- R43* (p.Arg43Ter), rs1555939523, ClinGen CA411502024, ClinVar RCV000660272, ClinVar RCV001290165, CADD 35.00, Pathogenic
- R43Q (p.Arg43Gln), cosmic curated COSV61005, TOPMed rs1932474865, REVEL 0.19, CADD 19.70
- A44D (p.Ala44Asp), 1000Genomes rs747377284, ExAC rs747377284, TOPMed rs747377284, gnomAD rs747377284, REVEL 0.21, CADD 20.40, Benign
- A44G (p.Ala44Gly), rs747377284, ClinGen CA10228723, ClinVar RCV000519667, ClinVar RCV000767097, REVEL 0.24, CADD 20.20, Conflicting interpretations, not specified; not provided; PCWH syndrome
- A44V (p.Ala44Val), 1000Genomes rs747377284, ExAC rs747377284, TOPMed rs747377284, gnomAD rs747377284, REVEL 0.20, CADD 21.70, Benign
- S45S (p.Ser45Ser), rs1932034454, gnomAD 22-37970994-T-C, CADD 0.02
- S45* (p.Ser45Ter), gnomAD 22-37970995-G-T, CADD 1.11
- S45T (p.Ser45Thr), rs538176019, gnomAD 22-37970996-A-T, CADD 0.23
- S45P (p.Ser45Pro), gnomAD 22-37970996-A-G, CADD 0.28
- P46L (p.Pro46Leu), rs1447194601, gnomAD rs1447194601, REVEL 0.24, CADD 22.60, Variant assessed as somatic; moderate impact.
- P46S (p.Pro46Ser), gnomAD rs1168500667, REVEL 0.14, CADD 19.90
- G47V (p.Gly47Val), gnomAD rs1391454829, Uncertain significance, not provided
- P48L (p.Pro48Leu), gnomAD rs1244786630, REVEL 0.14, CADD 18.70
- P48S (p.Pro48Ser), gnomAD rs1477467526
- P48P (p.Pro48Pro), gnomAD 22-37971000-A-T, CADD 4.48
- P48H (p.Pro48His), gnomAD 22-37971001-G-T, CADD 4.50
- P48R (p.Pro48Arg), gnomAD 22-37971001-G-C, CADD 4.45
- G49S (p.Gly49Ser), gnomAD rs1223421300, REVEL 0.16, CADD 16.00
- L51P (p.Leu51Pro), Ensembl rs2145777470
- L51L (p.Leu51Leu), gnomAD 22-37970985-G-T, CADD 3.30
- L51I (p.Leu51Ile), gnomAD 22-37970987-G-T, CADD 1.43
- L51F (p.Leu51Phe), rs1235703834, gnomAD 22-37970987-G-A, CADD 1.79
- G52A (p.Gly52Ala), Ensembl rs1932473127
- G52E (p.Gly52Glu), gnomAD 22-37971004-C-T, CADD 3.71, SIFT 0.00
- G52V (p.Gly52Val), gnomAD 22-37971004-C-A, CADD 3.29, SIFT 0.00
- K53N (p.Lys53Asn), ExAC rs778038020, TOPMed rs778038020, gnomAD rs778038020, REVEL 0.14, CADD 21.90
- K53Q (p.Lys53Gln), Ensembl rs2145777456, REVEL 0.19, CADD 22.10
- K53R (p.Lys53Arg), cosmic curated COSV10032
- V54I (p.Val54Ile), gnomAD rs1202924491, REVEL 0.16, CADD 19.80
- K55E (p.Lys55Glu), gnomAD rs1340193662, REVEL 0.38, CADD 20.10
- K55N (p.Lys55Asn), cosmic curated COSV10610, REVEL 0.22, CADD 20.60
- K56E (p.Lys56Glu), cosmic curated COSV10647, REVEL 0.47, CADD 22.50
- K56K (p.Lys56Lys), gnomAD 22-37970988-C-T, CADD 4.06
- K56T (p.Lys56Thr), rs1344502175, gnomAD 22-37970989-T-G, CADD 2.59
- K56* (p.Lys56Ter), gnomAD 22-37970990-T-A, CADD 2.75
- E57K (p.Glu57Lys), rs377075961, ClinGen CA10228721, cosmic curated COSV10647, ClinVar RCV001891516, REVEL 0.24, CADD 21.00, Conflicting interpretations, not provided
- Q58E (p.Gln58Glu), Ensembl rs1569171289
- Q59* (p.Gln59Ter), rs1367116894, NCI-TCGA Cosmic COSV6100, cosmic curated COSV61005, gnomAD rs1367116894, CADD 36.00, Variant assessed as somatic; high impact.
- Q59K (p.Gln59Lys), gnomAD rs1367116894, REVEL 0.15, CADD 17.90
- Q59L (p.Gln59Leu), TOPMed rs1273461073, gnomAD rs1273461073, REVEL 0.11, CADD 21.90
- Q59R (p.Gln59Arg), TOPMed rs1273461073, gnomAD rs1273461073
- Q59Q (p.Gln59Gln), rs1932033273, gnomAD 22-37970967-T-C, CADD 1.76
- Q59H (p.Gln59His), rs1932033273, gnomAD 22-37970967-T-G, CADD 1.53
- D60G (p.Asp60Gly), cosmic curated COSV61005, gnomAD rs1350814508
- D60N (p.Asp60Asn), rs1439127307, ClinGen CA411501749, ClinVar RCV001761359, TOPMed rs1439127307, REVEL 0.48, CADD 23.80, Conflicting interpretations, not provided
- D60V (p.Asp60Val), gnomAD rs1350814508, REVEL 0.45, CADD 23.30
- G61A (p.Gly61Ala), NCI-TCGA Cosmic COSV6100, cosmic curated COSV61005, Variant assessed as somatic; moderate impact.
- G61D (p.Gly61Asp), ExAC rs748667317, gnomAD rs748667317, REVEL 0.38, CADD 20.30
- G61S (p.Gly61Ser), rs866240813, ClinGen CA324166571, ClinVar RCV001328563, ClinVar RCV003135983, REVEL 0.28, CADD 18.20, Uncertain significance, not provided; PCWH syndrome
- E62K (p.Glu62Lys), NCI-TCGA Cosmic COSV1003, cosmic curated COSV10032, REVEL 0.47, CADD 22.80, Variant assessed as somatic; moderate impact.
- A63T (p.Ala63Thr), cosmic curated COSV10736
- A63V (p.Ala63Val), gnomAD 22-37970998-G-A, CADD 0.08
- A63S (p.Ala63Ser), gnomAD 22-37970999-C-A, CADD 0.78
- D64A (p.Asp64Ala), rs372400283, ClinGen CA10228719, ClinVar RCV002006662, ClinVar RCV004782855, REVEL 0.44, CADD 23.00, Conflicting interpretations, not specified; not provided
- D64E (p.Asp64Glu), TOPMed rs1315579578, gnomAD rs1315579578, REVEL 0.43, CADD 16.40
- D64G (p.Asp64Gly), ESP rs372400283, ExAC rs372400283, TOPMed rs372400283, gnomAD rs372400283, REVEL 0.49, CADD 23.30, Uncertain significance
- D64N (p.Asp64Asn), TOPMed rs1371901048, gnomAD rs1371901048, REVEL 0.46, CADD 22.90
- D64V (p.Asp64Val), rs372400283, ClinGen CA10228717, ClinVar RCV000221276, ClinVar RCV001509097, REVEL 0.51, CADD 23.10, Uncertain significance, not specified; not provided
- D65E (p.Asp65Glu), cosmic curated COSV10453
- D65H (p.Asp65His), TOPMed rs1413568253, gnomAD rs1413568253, REVEL 0.50, CADD 25.90, Uncertain significance, not provided
- D65N (p.Asp65Asn), cosmic curated COSV61005, TOPMed rs1413568253, gnomAD rs1413568253, REVEL 0.38, CADD 26.20, Uncertain significance
- D66E (p.Asp66Glu), TOPMed rs1422539913, gnomAD rs1422539913, REVEL 0.14, CADD 17.20, Uncertain significance, not provided
- D66N (p.Asp66Asn), TOPMed rs1932470883, gnomAD rs1932470883, REVEL 0.42, CADD 24.20
- K67A (p.Lys67Ala), rs2145777238, ClinGen CA2499226185, ClinVar RCV001353099, Pathogenic
- K67N (p.Lys67Asn), ExAC rs780878837, TOPMed rs780878837, gnomAD rs780878837
- K67R (p.Lys67Arg), TOPMed rs1932470631
- F68L (p.Phe68Leu), ExAC rs751332955, TOPMed rs751332955, gnomAD rs751332955, REVEL 0.55, CADD 24.80, Uncertain significance, Waardenburg syndrome; PCWH syndrome
- P69L (p.Pro69Leu), cosmic curated COSV10032
- P69S (p.Pro69Ser), ExAC rs763813431, gnomAD rs763813431, REVEL 0.66, CADD 26.00, Uncertain significance, not provided
- P69P (p.Pro69Pro), rs552198598, gnomAD 22-37970952-C-T, CADD 0.07
- P69Q (p.Pro69Gln), gnomAD 22-37970953-G-T, CADD 0.21
- P69H (p.Pro69His), gnomAD 22-37970971-G-T, CADD 2.68
- P69T (p.Pro69Thr), gnomAD 22-37970972-G-T, CADD 1.01
- V70A (p.Val70Ala), cosmic curated COSV61004, ExAC rs759674899, gnomAD rs759674899
- V70L (p.Val70Leu), ExAC rs765329363, TOPMed rs765329363, gnomAD rs765329363, REVEL 0.19, CADD 23.00
- V70M (p.Val70Met), rs765329363, cosmic curated COSV10966, ExAC rs765329363, TOPMed rs765329363, REVEL 0.36, CADD 25.10, Variant assessed as somatic; moderate impact.
- V70R (p.Val70Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- C71G (p.Cys71Gly), rs200683397, ClinGen CA10228708, ClinVar RCV000214833, ClinVar RCV000660274, REVEL 0.43, CADD 23.00, Uncertain significance, Waardenburg syndrome type 4C; not specified; not provided
- C71F (p.Cys71Phe), gnomAD 22-37970962-C-A, CADD 2.25
- I72M (p.Ile72Met), NCI-TCGA Cosmic COSV6100, Variant assessed as somatic; moderate impact.
- E74K (p.Glu74Lys), NCI-TCGA Cosmic COSV6100, cosmic curated COSV61005, Variant assessed as somatic; moderate impact.
- V76F (p.Val76Phe), cosmic curated COSV61005
- V76I (p.Val76Ile), NCI-TCGA Cosmic COSV1003, cosmic curated COSV10032, NCI-TCGA Cosmic COSV6100, REVEL 0.52, CADD 25.20, Variant assessed as somatic; moderate impact.
- Q78* (p.Gln78Ter), rs1555939491, ClinGen CA411501391, ClinVar RCV000627359, ClinVar RCV001290166, Pathogenic
- V79M (p.Val79Met), cosmic curated COSV10736
- S81N (p.Ser81Asn), cosmic curated COSV61005
- G82D (p.Gly82Asp), gnomAD rs1221132587, REVEL 0.69, CADD 26.20
- G82S (p.Gly82Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Y83* (p.Tyr83Ter), rs73415876, ClinGen CA118750, ClinVar RCV000007818, 1000Genomes rs73415876, Pathogenic
- D84N (p.Asp84Asn), rs1408558281, cosmic curated COSV61005, ClinGen CA411501301, ClinVar RCV003204111, AlphaMissense 1.00, MetaLR 0.89, Uncertain significance, Inborn genetic diseases
- D84Y (p.Asp84Tyr), cosmic curated COSV10590, gnomAD rs1408558281
- W85* (p.Trp85Ter), rs2145777262, ClinGen CA411501279, ClinVar RCV001785008, Ensembl rs2145777262, Pathogenic
- W85C (p.Trp85Cys), gnomAD 22-37970958-C-A, CADD 4.00
- W85L (p.Trp85Leu), gnomAD 22-37970959-C-A, CADD 4.18
- W85R (p.Trp85Arg), rs1192412502, gnomAD 22-37970960-A-T, CADD 1.78
- P89L (p.Pro89Leu), gnomAD rs1465167325
- P89S (p.Pro89Ser), cosmic curated COSV61005
- M90C (p.Met90Cys), rs2145777226, ClinGen CA2499226184, ClinVar RCV001542711, ClinVar RCV001775033, Pathogenic
- M90I (p.Met90Ile), gnomAD rs1356917370, REVEL 0.60, CADD 25.50
- M90L (p.Met90Leu), cosmic curated COSV61005, REVEL 0.55, CADD 25.20
- M90T (p.Met90Thr), cosmic curated COSV10966
- P91A (p.Pro91Ala), rs483353057, ClinGen CA156408, ClinVar RCV000119814, Likely pathogenic
- P91S (p.Pro91Ser), rs1177855369, ClinGen CA411501187, ClinVar RCV004457541, REVEL 0.68, CADD 26.80, Uncertain significance, Inborn genetic diseases
- P91T (p.Pro91Thr), gnomAD rs1177855369, REVEL 0.80, CADD 26.40
- V92L (p.Val92Leu), rs142113652, ClinGen CA10228700, ClinVar RCV000871484, ClinVar RCV001146313, REVEL 0.57, CADD 25.60, Conflicting interpretations, not specified; PCWH syndrome; Hearing impairment
- V92M (p.Val92Met), rs142113652, ClinGen CA10228701, cosmic curated COSV61005, ClinVar RCV002289238, REVEL 0.54, CADD 26.20, Conflicting interpretations, not provided; not specified; Waardenburg syndrome type 2E
- R93C (p.Arg93Cys), gnomAD rs1015818123, REVEL 0.80, CADD 31.00
- R93H (p.Arg93His), Ensembl rs2145777182
- V94A (p.Val94Ala), rs1451564399, ClinGen CA411501131, ClinVar RCV002838390, TOPMed rs1451564399, REVEL 0.49, CADD 24.30, Benign, not provided
- V94I (p.Val94Ile), NCI-TCGA Cosmic COSV1003, cosmic curated COSV10032, TOPMed rs1932467025, gnomAD rs1932467025, REVEL 0.50, CADD 22.70, Variant assessed as somatic; moderate impact.
- N95K (p.Asn95Lys), gnomAD 22-37970964-G-T, CADD 5.69
- N95T (p.Asn95Thr), gnomAD 22-37970965-T-G, CADD 0.35
- G96D (p.Gly96Asp), Ensembl rs2145777154, REVEL 0.59, CADD 25.30
- G96S (p.Gly96Ser), cosmic curated COSV10966, TOPMed rs1932466608
- A97S (p.Ala97Ser), TOPMed rs1932466363
- A97T (p.Ala97Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S98N (p.Ser98Asn), Ensembl rs952615401
- S98R (p.Ser98Arg), rs2518052482, ClinGen CA411500992, ClinVar RCV003055612, REVEL 0.60, CADD 22.70, Uncertain significance, not provided
- S100N (p.Ser100Asn), ESP rs374038201, ExAC rs374038201, TOPMed rs374038201, gnomAD rs374038201, REVEL 0.27, CADD 16.60
Public SOX10 analysis runs
- SOX10 analysis run — SOX10 (1,012 variants) — completed 2026-08-28